COVID-19 Cases With Acute Necrotizing Pancreatitis
Yıl 2022,
Cilt: 13 Sayı: 1, 8 - 12, 08.03.2022
Özlem Bilir
,
Teslime Ayaz
,
Alpaslan Ünlü
,
Filiz Taşçı
,
Gökhan Ersunan
Öz
Introduction: COVID-19 is a multisystemic condition that presents with different signs and symptoms. Studies conducted have shown that it shows its effect on different tissues through Angiotensin Converting Enzyme 2 receptors. In particular, gastrointestinal system symptoms have started to attract more attention.
Case Report: We present two COVID-19 cases, aged 82 and 70, presenting with acute pancreatitis without any other risk factors. An 82-year-old female patient had a fatal outcome despite the treatment, while a 70-year-old female patient was discharged for outpatient follow-up.
Conclusion: While COVID-19 patients are typically admitted with symptoms of respiratory system, some patients may have symptoms such as nausea-vomiting, diarrhoea and abdominal pain.
Kaynakça
-
Referans 1- Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, WAng H, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis 2020; ciaa270.
-
Referans 2- Gu J, Han B, Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology 2020; 158(6): 1518-9.
-
Referans 3- Guan W-J, Ni YZ, Hu Y, Liang HW, Ou QC, O X-J, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Eng J Med 2020; 382: 1708-20.
-
Referans 4- Wong SH, Lui RN, Sung JJ. Covid-19 and the digestive system. J. Gastroenterol Hepatol 2020; 35(5): 744-8.
-
Referans 5- Patel KP, Patel PA, Vunnam RR, Hewlett AT, Jain R, Jing R, et al. Gastrointestinal, hepatobiliary, and pancreatic manifestation of COVID-19. J Clin Virol 2020; 128: 104386.
-
Referans 6- Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z. ACE 2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol 2020; 18: 2128-30.
-
Referans 7- Wang F, Wang H, Fan J, Zhang Y, Zhao Q. Pancreatic injury patterns in patients with Coronavirus Disease 19 pneumonia. Gastroenterology 2020; 159: 367-70.
Yıl 2022,
Cilt: 13 Sayı: 1, 8 - 12, 08.03.2022
Özlem Bilir
,
Teslime Ayaz
,
Alpaslan Ünlü
,
Filiz Taşçı
,
Gökhan Ersunan
Kaynakça
-
Referans 1- Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, WAng H, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis 2020; ciaa270.
-
Referans 2- Gu J, Han B, Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology 2020; 158(6): 1518-9.
-
Referans 3- Guan W-J, Ni YZ, Hu Y, Liang HW, Ou QC, O X-J, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Eng J Med 2020; 382: 1708-20.
-
Referans 4- Wong SH, Lui RN, Sung JJ. Covid-19 and the digestive system. J. Gastroenterol Hepatol 2020; 35(5): 744-8.
-
Referans 5- Patel KP, Patel PA, Vunnam RR, Hewlett AT, Jain R, Jing R, et al. Gastrointestinal, hepatobiliary, and pancreatic manifestation of COVID-19. J Clin Virol 2020; 128: 104386.
-
Referans 6- Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z. ACE 2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol 2020; 18: 2128-30.
-
Referans 7- Wang F, Wang H, Fan J, Zhang Y, Zhao Q. Pancreatic injury patterns in patients with Coronavirus Disease 19 pneumonia. Gastroenterology 2020; 159: 367-70.